Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Rivera J et al Immunity 2008; 28: 1–4.
Doetschman T . Methods Mol Biol 2009; 530: 423–433.
Biswas S et al Cell Death Differ ; advance online publication 8 March 2013 doi doi:10.1038/cdd.2013.16.
Klopstock N et al PLoS One 2009; 4: e5025.
Weiss WA et al EMBO J 1997; 16: 2985–2995.
Donehower LA et al Mol Carcinog 1995; 14: 16–22.
Petiniot LK et al Mol Cell Biol 2002; 22: 3174–3177.
Reliene R et al DNA Repair 2006; 5: 651–653.
Valdar W et al Genetics 2006; 174: 959–984.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Puccini, J., Dorstyn, L. & Kumar, S. Genetic background and tumour susceptibility in mouse models. Cell Death Differ 20, 964 (2013). https://doi.org/10.1038/cdd.2013.35
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2013.35
This article is cited by
-
RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
Oncogene (2020)
-
Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model
Molecular Cancer (2014)
-
An unexpected role for caspase-2 in neuroblastoma
Cell Death & Disease (2014)